Clal Biotechnology (Israel) Financial Indicators Patterns

CBI -- Israel Stock  

ILS 287.70  0.50  0.17%

We suggest you to use Clal Biotechnology fundamental analysis to see if markets are presently mispricing the company. In plain English you can use it to find out if Clal Biotechnology is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. . We found thirty available fundamental indicators for Clal Biotechnology Industries Ltd which can be compared to its rivals. To make sure the equity is not overpriced, please confirm all Clal Biotechnology fundamentals including its Current Valuation, Gross Profit, Debt to Equity, as well as the relationship between Price to Book and Cash and Equivalents . Use Clal Biotechnology to protect your portfolios against small markets fluctuations. The stock experiences normal downward trend and little activity. Check odds of Clal Biotechnology to be traded at S284.82 in 30 days.

Clal Biotechnology Company Summary

Clal Biotechnology competes with Kamada Ltd, Compugen Ltd, BioTime, Pluristem Therapeutics, and Protalix BioTherapeutics. Clal Biotechnology Industries Ltd. is a private equity and venture capital firm specializing in development stage, pre-clinical incubation, seed, start-up, early venture, emerging growth, mid venture, late venture, PIPEs, and growth capital stages of financing. It operates as a subsidiary of Clal Industries and Investments Ltd. Clal Biotechnology operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange.

Clal Biotechnology Operating Margin vs Current Ratio

Clal Biotechnology Industries Ltd is rated below average in operating margin category among related companies. It is rated fifth in current ratio category among related companies .

Clal Biotechnology Systematic Risk

Function
Time Period
  Portfolio Suggestion    
  
Execute Function
 
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of thirty-eight. The Beta measures systematic risk based on how returns on Clal Biotechnology correlated with the market. If Beta is less than 0 Clal Biotechnology generally moves in the opposite direction as compared to the market. If Clal Biotechnology Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Clal Biotechnology is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Clal Biotechnology is generally in the same direction as the market. If Beta > 1 Clal Biotechnology moves generally in the same direction as, but more than the movement of the benchmark. View also all equity analysis or get more info about beta statistic functions indicator.

Distress Rating

Clal Biotechnology Financial Distress Probability

29%
Chance of Financial Distress
Clal Biotechnology Industries Ltd has less than 29 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info

Compare Clal Biotechnology

Compare Clal Biotechnology To Peers

Clal Biotechnology Opportunity Range

March 21, 2019 Opportunity Range

Check also Trending Equities. Please also try Pair Correlation module to compare performance and examine historical correlation between any two equity instruments.
Search macroaxis.com